ABSTRACT. To find the underlying cause of noncompaction of the ventricular myocardium (NVM), three Chinese families with probands who presented this problem were studied. After the family members were evaluated by echocardiography, the gene G4.5 (taffazin) was scanned by sequencing. Although X-linked inheritance could not be ruled out, NVM were thought to have a vague rule of inheritance in our data from 8 patients and 28 family members. We also did not identify any mutations in G4.5 in all samples. Our data suggest that other genes are responsible for the familial form of this disease.
INTRODUCTION
Noncompaction of the ventricular myocardium (NVM) is a rare congenital cardiomyopathy (Jenni et al., 2001 ) that results from abnormal arrest in endomyocardial embryogenesis (Weiford et al., 2004) and is characterized by the presence of prominent ventricular myocardial trabeculations and deep intertrabecular recesses, while the compacted myocardium is thin (Zambrano et al., 2002; Maron et al., 2006; Klaassen et al., 2008) . Some studies have showed that NVM is an autosomal dominant inherited disease (Sasse- Klaassen et al., 2003) and mutations in the G4.5 gene (taffazin) on the Xq28 chromosomal region may be responsible for some familial cases (Chin et al., 1990; Ichida et al., 2001; Chen et al., 2002; Kenton et al., 2004) . However, there are no genetic research results on NVM in China.
MATERIAL AND METHODS

Clinical evaluation
Three families from China were recruited for this study. Probands and available family members were evaluated by medical record review, physical examination and history taking, 24-h Holter monitoring, 12-lead electrocardiography, and echocardiography. All electrocardiography results were performed and reviewed by 2 or more independent observers according to institutional guidelines. The criteria for diagnosis were 1) the presence of prominent trabeculations with deep intertrabecular recesses; 2) the noncompacted endocardial layer was thicker than the compacted epicardial layer (ratio ≥2), and 3) the presence of deep recesses filled with blood from the ventricular cavity, as visualized by color Doppler imaging.
Mutation screening
Genomic DNA was isolated from peripheral blood using a Wizard Genomic DNA Purification kit (Takara, China). Primers were designed by Primer3 according to the NCBI database (Table 1) . Polymerase chain reaction (PCR) was performed in 50-µL reactions containing 2 U Pyrobest DNA Polymerase (Takara), 0.5 µM each of forward and reverse primers, and 50 ng genomic DNA in 1X Pyrobest buffer (containing MgCl 2 ). Amplification was performed with an initial step of 94°C for 5 min; followed by 30 cycles of 94°C for 30 s, annealing for 30 s, and 72°C for 30 s, and then 72°C for 10 min. PCR products were purified using a Qiagen PCR purification kit and sequenced using an ABI 3730 DNA Genetic Analyzer.
RESULTS
Study cohort
Three of 9 probands agreed to an extended pedigree analysis; their 1st-degree relatives were clinically evaluated and echocardiography was performed. The relatives of the remaining 6 probands were unavailable or declined to participate in the study, and we were consequently unable to determine whether these were sporadic or familial cases of NVM. In the 3 kindred evaluated, at least one or another affected relative was identified. Therefore, based on this investigation, these 3 probands were considered to have familial NVM (kindred NVM, Figure 1A -C).
5ꞌ-AGCTCGGAGAGGGCACTTGAG-3ꞌ Table 1 . Sequence of primers. F = forward and R = reverse primers; Tm = melting temperature. Figure 1 . Pedigree of the three families. All sampled subjects are identified by the Roman numerals below the symbol. Arabic numerals denote each individual in a generation. Open symbols = unaffected; filled symbols = affected; symbols with a diagonal line = deceased subjects; squares = males; circles = females; A. family 1; B. family 2; C. family 3.
Kindred NVM-1 was diagnosed in the proband ( Figure 1A ) when he was 17 years old and experienced atrial fibrillation. The cardiac status of the patient was evaluated. Echocardiography revealed dilatation of the left and right atria and left ventricle with barely normal systolic and abnormal diastolic function (LVEDD, 5.9 cm; LVEF, 56%) (Figure 2A and B) . The patient's PASP, measured from TR, was 110 mmHg (1 mmHg = 0.133 kPa). Tc-MAA pulmonary perfusion and ventilation imaging revealed blood flow reduction in the right lower basal segment of the pulmonary artery that could not match normal ventilation, suggesting pulmonary embolism. Three other members of kindred NVM-1 presented either heart failure or arrhythmia symptoms in their 4th decade of life. All of them were male. Individuals I-2 (75 years old), II-3 (45 years old), and II-5 (49 years old) exhibited typical features of noncompaction of the left ventricular apex and posterior wall: prominent left ventricular trabeculations; noncompacted endocardial layer less than 2 times thicker than the compacted epicardial layer. In kindred NVM-2 ( Figure 1B) , the proband (II-3), a 57-year-old woman, presented palpitation and shortness of breath upon admission, and on examination, moisture rales were heard on both sides; in the heart, a 3rd-degree systolic murmur was auscultated. Marked noncompaction confined to the left ventricular apex and enlargement of the left ventricle with reduced systolic function were identified (LVEDD, 6.1 cm; LVEF, 45%). Holter monitoring revealed a polymorphic ventricular premature beat, paroxysmal atrial tachycardia, and V5 ST depression. The proband's sister and brother, II-1 (61 years old) and II-6 (55 years old), respectively, have been diagnosed with NVM. Thus, from 3 generations (Figure 1B) , i.e., of 13 people, 3 individuals, including the proband, were diagnosed with NVM. The proband's siblings both experienced palpitation after exertion. Holter monitoring revealed that II-1 experienced frequent premature ventricular contractions; II-6 was noted to have atrial fibrillation. The history of the proband's mother, I-1, was confirmed: she had heart dysfunction for many years and died suddenly when she was 59 years old; the father, I-2, died of stroke when he was 72 years old, leaving insufficient details about any significant link to NVM.
In kindred NVM-3, the proband (II-1) was a 57-year-old woman. She was admitted after presenting complaints of repeated chest tightness ( Figure 1C ). On echocardiography, prominent trabeculations with deep intertrabecular recesses were found in the apex and inferior and lateral walls of the left ventricle. The noncompacted endocardial layer was thicker than the compacted epicardial layer (ratio = 2.5). Holter monitoring revealed paroxysmal 2nd-degree type 1 atrioventricular block. An angiogram revealed a normal coronary system. In this family, which spanned 3 generations (11 individuals), none but the proband was found to be affected with NVM. The proband's 72-year-old father, I-2, was diagnosed with hypertrophic cardiomyopathy when he was 68 years old; echocardiography and clinical symptoms supported the diagnosis.
G4.5 mutation analysis
Although X-linked inheritance could not be ruled out, NVM was thought to adhere to a vague rule of inheritance in these cases. Although mutations of the G4.5 gene were thought to be responsible for some familial cases of NVM, no mutants in either the probands or other samples were found in our research.
DISCUSSION
NVM is categorized as an unclassified cardiomyopathy in the World Health Organization Task Force report (Richardson et al., 1996) . The prevalence is approximately 0.014% (Kasifoglu et al., 2007) . Transthoracic echocardiography, transesophageal echocardiography, and magnetic resonance imaging are used to diagnose NVM.
On the basis of the data for the responsible G4.5 gene, Bleyl et al. (1997) proposed that NVM was an X-linked inherited disease. Ichida et al. (2001) noted that the autosomal dominant inheritance pattern also existed in NVM patients. Our results showed that although X-linked inheritance could not be ruled out, NVM in our cases was thought to adhere to a vague rule of inheritance. As in other heart muscle disorders, NVM demonstrates genetic heterogeneity. Mutations in genes encoding G4.5 (taffazin) have been reported as causes of the disease in several reports (Chin et al., 1990; Ichida et al., 2001; Chen et al., 2002) , but there are patients in whom no genetic basis of disease is found to be significant. Some studies reported that G4.5 mutations are rare in familial cases of NVM (Chen et al., 2002; Sasse-Klaassen et al., 2003; Kenton et al., 2004) . Klaassen et al. (2008) identified no mutations in 25 probands. In the study performed by Chen et al. (2002) mutations were identified in only 1 patient from 27 Japanese subjects. Our results also did not show G4.5 mutations in any of the subjects. Our data suggest that other genes are responsible for this disease, such as α-dystrobrevin, RyR2, MYH7, ACTC, and TNNT2 (Klaassen et al., 2008) .
